IrisVision

Private

Pleasanton, CaliforniaHealthcare & Life Scienceshttps://irisvision.com/

Last Round

Series A

Mar 20, 2022

Total Funding Raised

$18.2M

Company Overview

IrisVision is a healthtech company that develops and manufactures FDA-registered wearable devices to assist individuals with low vision conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, AR/VR Experiences, Computer Vision

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

assistive technologylow vision aidaccessibility techwearable medical deviceblindness assistive devicesmart glassesVRvirtual reality headsetcomputer visionvision rehabilitationmacular degeneration aidimage processing softwaredigital magnifiertelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IrisVision Comps

Public and private peers based on sector, stage, and business model.

IrisVision comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

IrisVision Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 20, 2022
Grant	Dec 12, 2019
Seed	Dec 12, 2019

View all Funding Rounds

IrisVision Investors

Notable investors and investment history

IrisVision investors
Investor	Rounds
Better Ventures	Seed
National Eye Institute (NIH)	Grant, Seed
Hanawa Group	Series A
Social Starts	Series A
Band of Angels	Series A, Seed
Outcomes Collective	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 12, 2019
Received grant funding from the National Eye Institute (NIH).
Dec 12, 2019
$6.5M round with participation from Better Ventures and NIH.

View all signals

IrisVision Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IrisVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IrisVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersPleasanton, California

Employee Range12

Year Founded2016

Last FundingMar 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.